Artax Biopharma Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
0
Ending by 2030
Oct 2034
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due May 7, 2027The maintenance fee for Chromene Derivatives as Inhibitors of Tcr-Nck Interaction (US 11,807,633) comes due May 7, 2027. Unpaid by Nov 8, 2027, it lapses early.
Recent changes
- 1 term has ended since Aug 21, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,131,647 | Chromene derivatives substituted by alkoxide as inhibitors of the TCR-Nck interaction In force · USPTO record | In force | USPTO record | |
| US 11,434,239 | Aza-dihydro-acridone derivatives In force · USPTO record | In force | USPTO record | |
| US 11,505,526 | Aryl-piperidine derivatives In force · USPTO record | In force | USPTO record | |
| US 10,696,663 | Chromene Derivatives as Inhibitors of Tcr-Nck Interaction In force · High confidence | In force | High confidence | |
| US 11,008,310 | Chromene Derivatives as Inhibitors of Tcr-Nck Interaction In force · High confidence | In force | High confidence | |
| US 11,807,633 | Chromene Derivatives as Inhibitors of Tcr-Nck Interaction In force · High confidence | In force | High confidence | |
| US 12,319,675 | Chromene Derivatives as Inhibitors of Tcr-Nck Interaction In force · Low confidence | In force | Low confidence |
Also on record, not counted in the 7: 1 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
1 pending